Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764920 · ClinicalTrials.gov registry record
Skin Imaging With Technologies in Development
A clinical trial of Pigmented Skin Lesion of Uncertain Nature, sponsored by University of California, Irvine.
- Active
- Registry status
- 750
- Enrollment target
- 1
- Study location
NCT00764920: Active study of Pigmented Skin Lesion of Uncertain Nature, sponsored by University of California, Irvine.
NCT00764920 is a study of Pigmented Skin Lesion of Uncertain Nature that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 750 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00764920, a study of Pigmented Skin Lesion of Uncertain Nature, is active but no longer recruiting, sponsored by University of California, Irvine.
- ACTIVE NOT RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to develop non-invasive imaging modalities for assessment of skin. This is a pilot study which will use multiple imaging modalities to collect information on normal and lesional skin. The researchers understand that the purpose of this study is not to evaluate any particular treatment and an investigation of a new therapeutic intervention would require an additional protocol. Skin conditions to be studied include vascular lesions, pigmentary disorders, inflammatory conditions and neoplasms.
Primary Outcome
Develop non-invasive imaging modalities for assessment of skin.
Conditions Studied
Interventions
- DEVICE non-invasive imaging modalities for assessment of skin
Study Locations (1)
California
- Beckman Laser Institute Medical Clinic - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2008-10 |
| Est. Completion | 2026-12 |
What the registry record for NCT00764920 still lists
NCT00764920 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pigmented Skin Lesion of Uncertain Nature appearing as the primary indexed condition, and to 1 intervention - of which non-invasive imaging modalities for assessment of skin is the first listed.
NCT00764920 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00764920 about?
NCT00764920 is a clinical study titled "Skin Imaging With Technologies in Development". The purpose of this research is to develop non-invasive imaging modalities for assessment of skin. This is a pilot study which will use multiple imaging modalities to collect information on normal and lesional skin. The researchers understand that the purpose of this study is not to evaluate any par...
What is the current status of trial NCT00764920?
This trial is currently active not recruiting. The enrollment target is 750 participants. The study started on 2008-10. Estimated completion is 2026-12.
What conditions does trial NCT00764920 study?
This clinical trial studies the following conditions: Pigmented Skin Lesion of Uncertain Nature.
What interventions are being tested in trial NCT00764920?
The interventions under investigation include: non-invasive imaging modalities for assessment of skin (DEVICE).
Who is sponsoring clinical trial NCT00764920?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00764920 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia